This cross-sectional study investigated women with invasive breast cancer who were missing components of receptor status (ER, PR, or ERBB2) by analyzing information about 321 913 cases from the population-based SEER 18 database. This evidence concerns the gene ERBB2 and invasive breast carcinoma.